郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价First pharmacophore model of CCR3 receptor antagonists and its homology model-assisted, stepwise virtual screening.

期刊：Chemical biology & drug design发表年份：2011作者：Vaibhav Jain; Parameswaran Saravanan; Akanksha Arvind; Chethampadi Gopi Mohan
阅读更多 →

药效评价hERG channel blockade by externally applied quaternary ammonium derivatives.

期刊：Biochimica et biophysica acta发表年份：2011作者：Kee-Hyun Choi; Chiman Song; Dongyun Shin; Sungnam Park
阅读更多 →

药效评价The selective sphingosine 1-phosphate receptor 1 agonist ponesimod protects against lymphocyte-mediated tissue inflammation.

期刊：The Journal of pharmacology and experimental therapeutics发表年份：2011作者：Luca Piali; Sylvie Froidevaux; Patrick Hess; Oliver Nayler; Martin H Bolli; Eva Schlosser; Christopher Kohl; Beat Steiner; Martine Clozel
阅读更多 →

药效评价Functional prokaryotic-eukaryotic chimera from the pentameric ligand-gated ion channel family.

期刊：Proceedings of the National Academy of Sciences of the United States of America发表年份：2011作者：Guillaume Duret; Catherine Van Renterghem; Yun Weng; Marie Prevost; Gustavo Moraga-Cid; Christèle Huon; James M Sonner; Pierre-Jean Corringer
阅读更多 →